JPRN-UMIN000026700已完成未知
The efficacy of omarigliptin in type 2 diabetic patients - The efficacy of omarigliptin in type 2 diabetic patients
Kawashima Hospital, Social Medical Corporation Kawashima Hospital Group0 个研究点目标入组 41 人开始时间: 2017年3月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 41
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients having infectious diseases, thyroid disease, or malignant tumors. Patients being treated with steroids and changing the dosage. Patients considering not eligible for this trial by attending doctors due to any medical reasons.
研究者
相似试验
已完成
不适用
The efficacy of vildagliptin on type 2 diabetic patients with basal-bolus insulin therapy in the short-term hospitalization (single-center, randomized, open-label, controlled study).Type 2 DiabetesJPRN-UMIN000011851ippon Medical School, Chiba-Hokusoh Hospital, Division of Endocrinology, Department of Medicine40
尚未招募
不适用
The effect of omarigliptin on glucose excursion using continuous glucose monitoring in the elderly patients with type2 diabetestype 2 diabetesJPRN-UMIN000021815Department of Endoclinology, Gifu University Graduate School of Medicine10
尚未招募
不适用
Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liverJPRN-UMIN000026549Kagawa prefectural central hospital25
尚未招募
Unknown
Effects of imeglimin in patients with type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000049071Ise Red Cross Hospital30
已完成
3 期
Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)Type 2 DiabetesNCT01841697Merck Sharp & Dohme LLC642